Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Dow
McKinsey
McKesson
AstraZeneca

Last Updated: October 2, 2022

Investigational Drug Information for Genz-10850


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Genz-10850?

Genz-10850 is an investigational drug.

There have been 9 clinical trials for Genz-10850. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2010.

The most common disease conditions in clinical trials are Gaucher Disease, Kidney Diseases, and Lipidoses. The leading clinical trial sponsors are Genzyme, a Sanofi Company and [disabled in preview].

Recent Clinical Trials for Genz-10850
TitleSponsorPhase
Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy MenGenzyme, a Sanofi CompanyPhase 1
Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy AdultsGenzyme, a Sanofi CompanyPhase 1
A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy AdultsGenzyme, a Sanofi CompanyPhase 1

See all Genz-10850 clinical trials

Clinical Trial Summary for Genz-10850

Top disease conditions for Genz-10850
Top clinical trial sponsors for Genz-10850

See all Genz-10850 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Dow
McKinsey
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.